Related Experiment Video

Updated: May 13, 2026

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection
07:54

Highly Efficient Transfection of Human THP-1 Macrophages by Nucleofection

Published on: September 2, 2014

[Inhibition of NHE1 down-regulates IL-8 expression and enhances p38 phosphorylation]

Wei Gao1, Yu-Juan Zhang, Hai-Rui Zhang

  • 1Chinese Academy of Medical Sciences, Tianjin, China.

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|March 15, 2013
PubMed

Insights

Inhibiting NHE1 (Na+/H+ exchanger 1) reduces IL-8 (interleukin-8) expression by increasing p38 phosphorylation. This finding offers insights into angiogenesis regulation and potential therapeutic targets.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis.
  • Vascular Endothelial Growth Factor (VEGF) is a key regulator of angiogenesis, but other factors also play significant roles.
  • The Na+/H+ exchanger 1 (NHE1) is implicated in various cellular processes, including proliferation and migration, and may influence angiogenesis.

Purpose of the Study:

  • To investigate the impact of NHE1 inhibition on angiogenic factors beyond VEGF.
  • To elucidate the molecular mechanisms by which NHE1 affects angiogenesis.
  • To determine the role of IL-8 (interleukin-8) and p38 MAPK signaling in NHE1-mediated angiogenesis.

Main Methods:

  • K562 cells were treated with cariporide, a specific NHE1 inhibitor.
  • Protein chip analysis was used to screen for changes in angiogenesis factors.
  • Real-time quantitative PCR (RT-qPCR) was employed to measure IL-8 expression levels.
  • Western blot analysis was performed to assess p38 phosphorylation.
  • Stable NHE1 interference in K562 cells was achieved.
  • Experiments involved treatment with a p38 inhibitor (SB203580).

Main Results:

  • Protein chip analysis revealed decreased IL-8 expression following cariporide treatment.
  • RT-qPCR confirmed the inhibitory effect of cariporide on IL-8 expression.
  • NHE1 inhibition by cariporide led to an increase in p38 phosphorylation.
  • Treatment with the p38 inhibitor SB203580 decreased IL-8 expression.
  • Inhibition of p38 signaling partially reversed the down-regulation of IL-8 induced by cariporide.

Conclusions:

  • NHE1 inhibition effectively reduces IL-8 expression.
  • The mechanism involves the up-regulation of p38 phosphorylation.
  • These findings suggest that NHE1 plays a role in regulating angiogenesis through the modulation of IL-8 and p38 signaling pathways.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...